Literature DB >> 34071279

Clinical Outcomes of Pediatric Chronic Intestinal Pseudo-Obstruction.

Dayoung Ko1, Hee-Beom Yang2, Joong Youn1, Hyun-Young Kim1,3.   

Abstract

Chronic intestinal pseudo-obstruction (CIPO) is an extremely rare condition with symptoms of recurrent intestinal obstruction without any lesions. The outcomes of pediatric CIPO and predictors for the outcomes have not yet been well established. We analyzed the clinical outcomes and associated factors for the outcomes of pediatric CIPO. We retrospectively reviewed 66 primary CIPO patients diagnosed between January 1985 and December 2017. We evaluated parenteral nutrition (PN) factors such as PN duration, PN use over 6 months, home PN, and mortality as outcomes. We selected onset age, presence of urologic symptoms, pathologic type, and involvement extent as predictors. The early-onset CIPO was found in 63.6%, and 21.2% of the patients presenting with urologic symptoms. Of the 66 patients, 47 and 11 had neuropathy and myopathy, respectively. The generalized involvement type accounted for 83.3% of the cases. At the last follow-up, 24.2% of the patients required home PN management. The mean duration of PN was 11.8 ± 21.0 months. The overall mortality rate of primary CIPO was 18.2%. PN factors were predicted by the urologic symptoms and extent of involvement. However, mortality was predicted by pathologic type. The onset age was not significantly associated with the outcomes. CIPO with urologic symptoms and generalized CIPO had poor PN outcomes. Myopathy is suggested as a predictor of mortality in children with primary CIPO.

Entities:  

Keywords:  chronic intestinal pseudo-obstruction; myopathy; neuropathy; parenteral nutrition; pediatrics

Year:  2021        PMID: 34071279     DOI: 10.3390/jcm10112376

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  21 in total

Review 1.  Pathophysiology, Diagnosis, and Management of Chronic Intestinal Pseudo-Obstruction.

Authors:  Thomas J Downes; Manikandar S Cheruvu; Tennekoon B Karunaratne; Roberto De Giorgio; Adam D Farmer
Journal:  J Clin Gastroenterol       Date:  2018-07       Impact factor: 3.062

2.  Differential regulation of two FLNA transcripts explains some of the phenotypic heterogeneity in the loss-of-function filaminopathies.

Authors:  Zandra A Jenkins; Alison Macharg; Cheng-Yee Chang; Margriet van Kogelenberg; Tim Morgan; Sophia Frentz; Wenhua Wei; Jacek Pilch; Mark Hannibal; Nicola Foulds; George McGillivray; Richard J Leventer; Sixto García-Miñaúr; Stuart Sugito; Scott Nightingale; David M Markie; Tracy Dudding; Raj P Kapur; Stephen P Robertson
Journal:  Hum Mutat       Date:  2017-11-02       Impact factor: 4.878

3.  Paediatric Intestinal Pseudo-obstruction: Evidence and Consensus-based Recommendations From an ESPGHAN-Led Expert Group.

Authors:  Nikhil Thapar; Efstratios Saliakellis; Marc A Benninga; Osvaldo Borrelli; Joe Curry; Christophe Faure; Roberto De Giorgio; Girish Gupte; Charles H Knowles; Annamaria Staiano; Yvan Vandenplas; Carlo Di Lorenzo
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-06       Impact factor: 2.839

4.  Chronic intestinal pseudoobstruction syndrome: clinical analysis, outcome, and prognosis in 105 children. French-Speaking Group of Pediatric Gastroenterology.

Authors:  C Faure; O Goulet; S Ategbo; A Breton; P Tounian; J L Ginies; B Roquelaure; C Despres; M Scaillon; C Maurage; I Paquot; M Hermier; S De Napoli; A Dabadie; F Huet; J J Baudon; M Larchet
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

Review 5.  Megacystis microcolon intestinal hypoperistalsis syndrome: systematic review of outcome.

Authors:  Jan-Hendrik Gosemann; Prem Puri
Journal:  Pediatr Surg Int       Date:  2011-10       Impact factor: 1.827

6.  Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults.

Authors:  S D Mann; H S Debinski; M A Kamm
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

7.  Infantile chronic idiopathic intestinal pseudo-obstruction: the role of small intestinal manometry as a diagnostic tool and prognostic indicator.

Authors:  J M Fell; V V Smith; P J Milla
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

8.  Chronic intestinal pseudo-obstruction: treatment and long term follow up of 44 patients.

Authors:  S Heneyke; V V Smith; L Spitz; P J Milla
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

Review 9.  Health-related quality of life and neurodevelopmental outcomes among children with intestinal failure.

Authors:  Maria Hukkinen; Laura Merras-Salmio; Mikko P Pakarinen
Journal:  Semin Pediatr Surg       Date:  2018-07-29       Impact factor: 2.754

10.  ACTG2-Associated Visceral Myopathy With Chronic Intestinal Pseudoobstruction, Intestinal Malrotation, Hypertrophic Pyloric Stenosis, Choledochal Cyst, and a Novel Missense Mutation.

Authors:  Rebecca R J Collins; Bradley Barth; Stephen Megison; Cory M Pfeifer; Luke M Rice; Samar Harris; Charles F Timmons; Dinesh Rakheja
Journal:  Int J Surg Pathol       Date:  2018-07-18       Impact factor: 1.271

View more
  2 in total

1.  Changes in the intestinal expression of drug metabolism-related genes in a piglet model of parenteral nutrition.

Authors:  Li-Na Dai; Yu-Ling Zhao; Lu Jiang; Jun-Kai Yan
Journal:  Nutr Metab (Lond)       Date:  2022-03-09       Impact factor: 4.169

2.  Special Issue "Clinical Advances in Chronic Intestinal Diseases Treatment".

Authors:  Eva Latorre; Jose Emilio Mesonero
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.